Pirifibrate
Code | Size | Price |
---|
TAR-T34080-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T34080-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T34080-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Pirifibrate can be used for the treatment of hyperlipoproteinemia.
CAS:
21550-30-1
Formula:
C17H19Cl2NO4
Molecular Weight:
372.24
Purity:
0.98
SMILES:
Cl.CC(C)(Oc1ccc(Cl)cc1)C(=O)OCc1cccc(CO)n1
References
Bonora V, Calalabuig RJ, Caviola E, Soler J, Pueyo JM, Mical? T, Cano RP. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations. Clin Ther. 1981;4(3):192-200. PubMed PMID: 7030489.
Lopez Rodriguez J, Martorell J. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV. Clin Ther. 1980;3(4):234-41. PubMed PMID: 7273061.
de la Fuente R, Santos M. [Toxicological and pharmacological studies on a new drug: pirfibrate (EL-466) (author's transl)]. Arch Farmacol Toxicol. 1980 Dec;6(3):255-64. Spanish. PubMed PMID: 7305456.
Domingo AJ, Guti?rrez JA, Men?ndez JA, Mic? L, Mu?oz M, de Oya M. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study. Clin Ther. 1980;3(3):219-26. PubMed PMID: 7459931.